New Mountain's private equity strategy seeks to acquire the highest quality leaders in carefully selected growth industries.
New Mountain Vantage Advisers, LLC ("Vantage") holds non-control positions in the U.S. public equity market.
New Mountain’s credit strategy applies the firm’s “defensive growth” industry approach to the debt portion of the capital structure.
Andre V. Moura
Managing Director

Andre Moura, Managing Director, joined New Mountain in 2005. He previously worked at McKinsey from 2003 to 2005, where he helped to advise companies across various industries.

He received his A.B., magna cum laude, in Computer Science from Harvard College and his M.B.A., with high distinction, from Harvard Business School in 2009, where he was a Baker Scholar. He currently serves as a director of Aceto, Alteon Health, Avantor, Bellerophon, Gelest, Sparta Systems and Topix Pharmaceuticals. He previously served as a director of ACA Compliance Group, Medical Specialties Distributors and NuSil.